The CATIE schizophrenia effectiveness trial.
Delisi
L E
LE
Nasrallah
H A
HA
D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001569:Benzodiazepines / Q000008:administration & dosage / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003987:Dibenzothiazepines / Q000008:administration & dosage / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004361:Drug Tolerance; D006801:Humans; D000077152:Olanzapine; D010546:Perphenazine / Q000008:administration & dosage / Q000627:therapeutic use*; D000069348:Quetiapine Fumarate; D018967:Risperidone / Q000008:administration & dosage / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy*; D016896:Treatment Outcome
D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D001569:Benzodiazepines; D000069348:Quetiapine Fumarate; D010546:Perphenazine; D018967:Risperidone; D000077152:Olanzapine